{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:40:40Z","timestamp":1784860840084,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013286","name":"Specialized Research Fund for the Doctoral Program of Higher Education of China","doi-asserted-by":"crossref","award":["20130171120069"],"award-info":[{"award-number":["20130171120069"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013286","name":"Specialized Research Fund for the Doctoral Program of Higher Education of China","doi-asserted-by":"crossref","award":["20130171120077"],"award-info":[{"award-number":["20130171120077"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007162","name":"Science and Technology Department, Guangdong Province","doi-asserted-by":"publisher","award":["2014A020212477"],"award-info":[{"award-number":["2014A020212477"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Guangdong Province, China","award":["2015A030313035"],"award-info":[{"award-number":["2015A030313035"]}]},{"name":"Science and Technology Department of Guangzhou City, China","award":["201400000004-2"],"award-info":[{"award-number":["201400000004-2"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.cca.2016.06.010","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T15:39:16Z","timestamp":1466005156000},"page":"170-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China"],"prefix":"10.1016","volume":"459","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9336-8397","authenticated-orcid":false,"given":"Laisheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaorong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2016.06.010_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cca.2016.06.010_bb0010","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bjc.6604299","article-title":"The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?","volume":"98","author":"Chan","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cca.2016.06.010_bb0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2012.09.034","article-title":"The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass","volume":"128","author":"Chan","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2016.06.010_bb0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2008.11.011","article-title":"Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands","volume":"112","author":"Vernooij","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2016.06.010_bb0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1155\/S1064744998000362","article-title":"Clinical utility of CA125 levels in predicting laparoscopically confirmed salpingitis in patients with clinically diagnosed pelvic inflammatory disease","volume":"6","author":"Moore","year":"1998","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2016.06.010_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/01443610252971320","article-title":"Exceptionally high levels of CA125 due to endometriosis","volume":"22","author":"Caroline","year":"2002","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.cca.2016.06.010_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yasu.2011.04.002","article-title":"The past, present, and future of biomarkers: a need for molecular beacons for the clinical management of pancreatic cancer","volume":"45","author":"Brody","year":"2011","journal-title":"Adv. Surg."},{"key":"10.1016\/j.cca.2016.06.010_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2010.05.077","article-title":"CA125 in heart failure: implications for immunoinflammatory activity","volume":"146","author":"Turgut","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2016.06.010_bb0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nm.2989","article-title":"Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2016.06.010_bb0050","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstrom","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.cca.2016.06.010_bb0055","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-11-0635","article-title":"Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management","volume":"20","author":"Bandiera","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2016.06.010_bb0060","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1515\/cclm-2011-0477","article-title":"Diagnostic value of HE4 for ovarian cancer: a meta-analysis","volume":"50","author":"Yu","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2016.06.010_bb0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2016.06.010_bb0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2012.07.106","article-title":"Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass","volume":"127","author":"Karlsen","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2016.06.010_bb0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2013.01.018","article-title":"A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass","volume":"129","author":"Kaijser","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2016.06.010_bb0080","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1007\/s13277-014-1811-6","article-title":"Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2016.06.010_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2012.09.034","article-title":"The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass","volume":"128","author":"Chan","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2016.06.010_bb0090","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1373\/clinchem.2008.105601","article-title":"National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers","volume":"54","author":"Sturgeon","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.06.010_bb0095","doi-asserted-by":"crossref","first-page":"437","DOI":"10.6061\/clinics\/2012(05)06","article-title":"A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses","volume":"67","author":"Anton","year":"2012","journal-title":"Clinics"},{"key":"10.1016\/j.cca.2016.06.010_bb0100","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s13277-014-2738-7","article-title":"Evaluation of human epididymis protein 4 (HE4) and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women","volume":"36","author":"Fujiwara","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.cca.2016.06.010_bb0105","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1007\/s13277-014-1945-6","article-title":"HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer","volume":"35","author":"Ortiz-Munoz","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.cca.2016.06.010_bb0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jclinpath-2012-201031","article-title":"Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review","volume":"66","author":"Ferraro","year":"2013","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cca.2016.06.010_bb0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/AOG.0b013e318224fce2","article-title":"Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass","volume":"118","author":"Moore","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2016.06.010_bb0125","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.ejca.2011.12.003","article-title":"Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses","volume":"48","author":"Van Gorp","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cca.2016.06.010_bb0130","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1007\/s13277-014-1945-6","article-title":"HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer","volume":"35","author":"Ortiz-Munoz","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2016.06.010_bb0135","doi-asserted-by":"crossref","first-page":"437","DOI":"10.6061\/clinics\/2012(05)06","article-title":"A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses","volume":"67","author":"Anton","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.cca.2016.06.010_bb0140","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002402","article-title":"Comparison of HE4, CA125, and ROMA diagnostic accuracy: a prospective and multicenter study for Chinese women with epithelial ovarian cancer","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2016.06.010_bb0145","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3346\/jkms.2015.30.12.1777","article-title":"Comparison of HE4, CA125, and risk of ovarian malignancy algorithm in the prediction of ovarian cancer in Korean women","volume":"30","author":"Cho","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.cca.2016.06.010_bb0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2016.01.016","article-title":"HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: an Italian multicenter study","volume":"141","author":"Romagnolo","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2016.06.010_bb0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cca.2014.09.028","article-title":"Clinical performance of two multi-marker blood tests for predicting malignancy in women with an adnexal mass","volume":"438","author":"Grenache","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2016.06.010_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2014.11.013","article-title":"Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses","volume":"440","author":"Chen","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2016.06.010_bb0165","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2008.04.002","article-title":"Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus","volume":"110","author":"Moore","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2016.06.010_bb0170","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.26433","article-title":"The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer","volume":"131","author":"Nicklin","year":"2012","journal-title":"Int. J. Cancer"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898116302558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898116302558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T23:20:11Z","timestamp":1589671211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898116302558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":33,"alternative-id":["S0009898116302558"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2016.06.010","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2016.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}